• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物转化法合成螺内酯的两种新羟基衍生物。

Synthesis of two new hydroxylated derivatives of spironolactone by microbial transformation.

机构信息

Department of Biological Engineering, Utah State University, 4105 Old Main Hill, Logan, UT 84322, United States; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, Zhejiang 310032, China.

Department of Biological Engineering, Utah State University, 4105 Old Main Hill, Logan, UT 84322, United States.

出版信息

Bioorg Med Chem Lett. 2014 Jul 15;24(14):3023-5. doi: 10.1016/j.bmcl.2014.05.038. Epub 2014 May 22.

DOI:10.1016/j.bmcl.2014.05.038
PMID:24894559
Abstract

Spironolactone is a medicinally important molecule that is clinically used in the treatment and management of many diseases such as oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, chronic lung disease, resistant hypertension, congestive heart failure, and primary hyperaldosteronism. Microbial transformations of spironolactone by Cunninghamella elegans ATCC 9245 was carried out. Two new hydroxylated derivatives, 12β-hydroxy-spironolactone and 2α-hydroxy-spironolactone, were synthesized. Their structures were characterized on the basis of the spectroscopic data. The substrate can be efficiently converted into the products within 72 h after its addition to the fermentation broth of C. elegans ATCC 9245.

摘要

螺内酯是一种具有医学重要性的分子,临床上用于治疗和管理许多疾病,如肝硬变的水肿和腹水、恶性腹水、肾病综合征、慢性肺病、耐药性高血压、充血性心力衰竭和原发性醛固酮增多症。用卷枝毛霉 ATCC 9245 对螺内酯进行微生物转化。合成了两种新的羟化衍生物 12β-羟基螺内酯和 2α-羟基螺内酯。根据光谱数据对其结构进行了表征。在向 C.elegans ATCC 9245 的发酵液中加入底物后,72 小时内可以有效地将其转化为产物。

相似文献

1
Synthesis of two new hydroxylated derivatives of spironolactone by microbial transformation.微生物转化法合成螺内酯的两种新羟基衍生物。
Bioorg Med Chem Lett. 2014 Jul 15;24(14):3023-5. doi: 10.1016/j.bmcl.2014.05.038. Epub 2014 May 22.
2
Microbial hydroxylation of bufalin by Cunninghamella blakesleana and Mucor spinosus.布氏被孢霉和刺状毛霉对蟾毒灵的微生物羟基化作用。
J Nat Prod. 2005 Apr;68(4):626-8. doi: 10.1021/np0500023.
3
Biotransformation of cinobufagin by Cunninghamella elegans.
J Antibiot (Tokyo). 2007 Apr;60(4):261-4. doi: 10.1038/ja.2007.32.
4
Whole-Cell Mediated 11β-Hydroxylation on the Basic Limonoid Skeleton by Cunninghamella echinulata.刺孢小克银汉霉对基本柠檬苦素骨架的全细胞介导11β-羟基化作用
J Org Chem. 2015 Jun 19;80(12):6490-5. doi: 10.1021/acs.joc.5b00417. Epub 2015 May 29.
5
A novel dihydroxylated derivative of artemisinin from microbial transformation.一种通过微生物转化得到的新型青蒿素二羟基化衍生物。
Fitoterapia. 2017 Jul;120:93-97. doi: 10.1016/j.fitote.2017.05.015. Epub 2017 May 30.
6
Biotransformation of ruscogenins by Cunninghamella blakesleeana NRRL 1369 and neoruscogenin by endophytic fungus Neosartorya hiratsukae.被 Cunninghamella blakesleeana NRRL 1369 转化的瑞香素和内生真菌 Neosartorya hiratsukae 转化的新瑞香素。
Phytochemistry. 2018 Aug;152:1-9. doi: 10.1016/j.phytochem.2018.04.002. Epub 2018 Apr 22.
7
Microbial transformation of diosgenin by filamentous fungus Cunninghamella echinulata.丝状真菌刺孢小克银汉霉对薯蓣皂苷元的微生物转化
J Asian Nat Prod Res. 2011 Mar;13(3):270-5. doi: 10.1080/10286020.2010.551117.
8
Bioconversion of Stemodia maritima diterpenes and derivatives by Cunninghamella echinulata var. elegans and Phanerochaete chrysosporium.刺孢小克银汉霉优雅变种和黄孢原毛平革菌对海滨水蓑衣二萜及其衍生物的生物转化
Phytochemistry. 2006 Jun;67(11):1088-93. doi: 10.1016/j.phytochem.2006.04.001. Epub 2006 May 24.
9
Microbial transformation of acetyl-11-keto-boswellic acid by Cunninghamella elegans.
J Asian Nat Prod Res. 2013 Nov;15(11):1173-8. doi: 10.1080/10286020.2013.837455. Epub 2013 Oct 29.
10
Microbial transformation of mestranol by Cunninghamella elegans.线虫 Cunninghamella elegans 对炔雌醇的微生物转化
Chem Pharm Bull (Tokyo). 2005 Aug;53(8):1011-3. doi: 10.1248/cpb.53.1011.